A detailed history of Gsa Capital Partners LLP transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 110,785 shares of HCAT stock, worth $860,799. This represents 0.05% of its overall portfolio holdings.

Number of Shares
110,785
Previous 11,169 891.9%
Holding current value
$860,799
Previous $84,000 742.86%
% of portfolio
0.05%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$5.53 - $7.28 $550,876 - $725,204
99,616 Added 891.9%
110,785 $708,000
Q1 2024

May 03, 2024

SELL
$7.44 - $11.21 $213,416 - $321,558
-28,685 Reduced 71.98%
11,169 $84,000
Q4 2023

Feb 16, 2024

BUY
$6.71 - $10.16 $267,420 - $404,916
39,854 New
39,854 $369,000
Q4 2022

Feb 13, 2023

BUY
$6.86 - $11.32 $712,925 - $1.18 Million
103,925 New
103,925 $1.11 Million
Q2 2022

Aug 09, 2022

BUY
$11.79 - $27.63 $1.1 Million - $2.58 Million
93,315 New
93,315 $1.35 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $425M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.